Merck & Co (NYSE:MRK) reported quarterly earnings of $1.80 per share which beat the analyst consensus estimate of $1.53 by 17.65 percent. This is a 36.36 percent increase over earnings of $1.32 per share from the same period last year. The company reported quarterly sales of $13.52 billion which beat the analyst consensus estimate of $13.16 billion by 2.74 percent. This is a 8.05 percent increase over sales of $12.51 billion the same period last year.
Merck & Co Q4 EPS $1.80 Beats $1.53 Estimate, Sales $13.52B Beat $13.16B Estimate
Merck & Co (NYSE:MRK) reported quarterly earnings of $1.80 per share which beat the analyst consensus estimate of $1.53 by 17.65 percent. This is a 36.36 percent increase over earnings of $1.32 per share from the same
